Radiographic progression-free survival in the ACIS trial for prostate cancer reply

被引：0
|
作者：
Saad, Fred [1 ]
De Porre, Peter [2 ]
Brookman-May, Sabine [3 ,4 ]
Li, Jinhui [5 ]
McCarthy, Sharon A. [6 ]
Rathkopf, Dana E. [7 ,8 ]
机构：
[1] Univ Montreal, Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[2] Janssen Res & Dev, Beerse, Belgium
[3] Janssen Res & Dev, Los Angeles, CA USA
[4] Ludwig Maximilians Univ Munchen, Munich, Germany
[5] Janssen Res & Dev, San Diego, CA USA
[6] Janssen Res & Dev, Raritan, NJ USA
[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[8] Weill Cornell Med, New York, NY USA
来源：
LANCET ONCOLOGY | 2022年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E5 / E6
页数：2
相关论文
共 50 条
  • [21] Progression-free survival end points in prostate cancer: are we truly making progress
    Madan, Ravi A.
    Posadas, Edwin M.
    Lee, Richard J.
    NATURE REVIEWS UROLOGY, 2024, 21 (11) : 646 - 648
  • [22] Progression-free survival is a surrogate for survival in advanced colorectal cancer
    Buyse, Marc
    Burzykowski, Tomasz
    Carroll, Kevin
    Michiels, Stefan
    Sargent, Daniel J.
    Miller, Langdon L.
    Elfring, Gary L.
    Pignon, Jean-Pierre
    Piedbois, Pascal
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5218 - 5224
  • [23] Radiographic Progression-Free Survival As a Response Biomarker in Metastatic Castration-Resistant Prostate Cancer: COU-AA-302 Results
    Morris, Michael J.
    Molina, Arturo
    Small, Eric J.
    de Bono, Johann S.
    Logothetis, Christopher J.
    Fizazi, Karim
    de Souza, Paul
    Kantoff, Philip W.
    Higano, Celestia S.
    Li, Jinhui
    Thian Kheoh
    Larson, Steven M.
    Matheny, Shannon L.
    Naini, Vahid
    Burzykowski, Tomasz
    Griffin, Thomas W.
    Scher, Howard I.
    Ryan, Charles J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (12) : 1356 - +
  • [24] Association of calcium channel blocker use with prostate cancer aggressiveness, progression-free survival, and overall survival
    Poch, Michael Adam
    Mehedint, Diana
    Curtis, Alexandra
    Attwood, Kristopher
    Wilding, Gregory E.
    Ondracek, Rochelle Payne
    Underwood, Willie
    Schwaab, Thomas
    Guru, Khurshid
    Mohler, James
    Heemers, Hannelore
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Improved progression-free survival in metastatic breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2018, 19 (02): : E79 - E79
  • [26] Niraparib improves progression-free survival in ovarian cancer
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2019, 20 (11): : E615 - E615
  • [27] Prolonged progression-free survival in metastatic breast cancer
    Mayor, Susan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (07) : 378 - 378
  • [28] Vandetanib improves progression-free survival in lung cancer
    Mayor, Susan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (07) : 378 - 378
  • [29] Bevacizumab improves progression-free survival in ovarian cancer
    Mayor, Susan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (07) : 371 - 371
  • [30] Radiographic progression-free survival correlation with time-to-event endpoints: A post hoc analysis of the VISION trial
    Morris, M. J.
    de Bono, J. S.
    Nagarajah, J.
    Wei, X. X.
    Nordquist, L. T.
    Koshkin, V. S.
    Vickers, A.
    Mirante, O.
    Ghouse, R.
    Tagawa, S. T.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1170 - S1171
12345